⌘K
Loading ticker…
Edgewise Therapeutics, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Edgewise Therapeutics, Inc. Common Stock (EWTX) has a 3-month relative strength percentile of 81 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 79. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 7.4%, relative volume 1.47×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 81, Market Stance is mixed at 47, A/D rating D
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
EWTX is in a stage 2 uptrend, week 3. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 20.2% / 55.7%.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
EWTX is held by 6 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $90M notional. Top 3 carry $168M.
Top 6 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $90M |
| IWMiShares Russell 2000 ETF | 0.07% | $52M |
| VXFVanguard Extended Market ETF | 0.03% | $26M |
| IWOiShares Russell 2000 Growth ETF | 0.14% | $17M |
| XPHState Street SPDR S&P Pharmaceuticals ETF | 1.95% | $6M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $3M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EWTX Jan avg: 23.95% median: 13.93% win: 100% σ: 26.37% n: 4 2022-04-12 → 2026-05-29 | EWTX Feb avg: -3.31% median: -6.48% win: 25% σ: 7.68% n: 4 2022-04-12 → 2026-05-29 | EWTX Mar avg: -7.78% median: -6.23% win: 50% σ: 19.00% n: 4 2022-04-12 → 2026-05-29 | EWTX Apr avg: -0.73% median: -1.71% win: 20% σ: 20.51% n: 5 2022-04-12 → 2026-05-29 | EWTX May avg: -2.68% median: -4.52% win: 40% σ: 15.53% n: 5 2022-04-12 → 2026-05-29 | EWTX Jun avg: 0.22% median: -1.53% win: 50% σ: 21.53% n: 4 2022-04-12 → 2026-05-29 (current) | EWTX Jul avg: 4.72% median: 1.67% win: 50% σ: 13.09% n: 4 2022-04-12 → 2026-05-29 | EWTX Aug avg: 0.18% median: 2.44% win: 75% σ: 10.39% n: 4 2022-04-12 → 2026-05-29 | EWTX Sep avg: 11.17% median: 5.33% win: 50% σ: 22.65% n: 4 2022-04-12 → 2026-05-29 | EWTX Oct avg: 11.70% median: 12.20% win: 75% σ: 11.91% n: 4 2022-04-12 → 2026-05-29 | EWTX Nov avg: 7.47% median: -3.35% win: 25% σ: 23.39% n: 4 2022-04-12 → 2026-05-29 | EWTX Dec avg: 14.01% median: -2.41% win: 25% σ: 44.69% n: 4 2022-04-12 → 2026-05-29 |